Role of NFκB in age-related vascular endothelial
























Cardiovascular diseases (CVD) are the leading cause of 
morbidity and mortality in the United States and other 
industrialized societies. Older age is the major risk 
factor for development of CVD [1]. Emerging evidence 
over the past 20 years suggests that the arterial vascular 
endothelium plays a critical role in the development of 
CVD, most notably, atherosclerosis. A healthy vascular 
endothelium is characterized by a tightly regulated 
balance of pro- and anti-oxidants, vasodilators and 
vasoconstrictors, and pro- and anti-inflammatory 
molecules. A diseased or dysfunctional endothelium 
displays a “pro-atherogenic” phenotype, losing its 
tightly regulated balance and adopting a pro-
oxidant/vasoconstrictor/pro-inflammatory phenotype. A 
hallmark of arterial endothelial dysfunction is impaired 
endothelial dependent dilation, which is predictive of 
future CVD events [1, 2].  
 
Aging leads to impaired endothelial dependent dilation 
associated elevated oxidative stress and a pro-
inflammatory endothelial cell phenotype. Recent studies 
in humans by our group and by others in rodents 
suggest a critical role of nuclear factor κB (NFκB) in 
the pro-inflammatory / pro-oxidant linked suppression 
of endothelial dependent dilation with advancing aging 
[3-7]. This perspective will discuss new information 
concerning the role of increased NFκB signaling in 
mediating vascular endothelial dysfunction with aging 











































NFκB is an important transcription factor expressed in 
all mammalian cell types.  It is responsible for 
regulating gene expression of factors that control cell 
adhesion, proliferation, inflammation, redox status, and 
tissue specific enzymes. In arteries, NFκB is thought to 
promote CVD through its pro-inflammatory, pro-
adhesion and pro-oxidant gene transcription. Recent 
evidence, however, suggests that not all NFκB-
mediated gene regulation may be deleterious to the 
vascular system. For example, acute shear stress evoked 
increases in endothelial nitric oxide synthase, the 
enzyme that synthesizes the vascular protective 
molecule nitric oxide, is NFκB dependent [8].  The 
complexity in the control of NFκB signaling provides 
insight into how this transcription factor can have such 
diversity of regulatory responsibilities.  
 
The NFκB activation pathway is triggered by a wide 
variety of stimuli including inflammatory cytokines, 
reactive oxygen species, lipids and mechanical forces 
acting on the vascular endothelial wall leading to 
stimulation of transmembrane receptors. This triggers 
intracellular signaling pathways leading to an activation 
of a kinase (IκK) mediated phosphorylation and 
degradation of the inhibitor of NFκB (IκB). This results 
in translocation of the NFκB heterodimer (p65/p50 
subunits and, perhaps, p65, RelB, c-Rel, p50 and p52) 
to the nucleus where it binds to promoters of gene 
targets. Some potential gene targets that predispose the 
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“proatherogenic” phenotype are pro-inflammatory 
molecules such as interleukin-6 (IL-6), tumor necrosis 
factor-α (TNF-α) monocyte chemoattractant protein 1 
(MCP-1), receptor for advance glycation endproducts 
(RAGE) and the pro-oxidant enzyme NADPH oxidase 
[9-11]. 
 
Aging is associated with chronic, low-grade 
inflammation characterized by increases in circulating 
acute phase proteins C-reactive protein (CRP) and pro-
inflammatory cytokines [12], such as TNF-α [13] and 
IL-6 [14]. Recently, we demonstrated that total NFκB 
protein was elevated in vascular endothelial cells 
collected in obese [15] and older [6] adults compared 
with normal weight, young controls. In a follow-up 
study, we determined if the age-associated increase in 
total NFκB expression was associated with increased 
signaling and downstream pro-inflammatory gene 
expression [5]. We found that endothelial dependent 
dilation was impaired in older adults and was associated 
with increased nuclear translocation of NFκB in their 
vascular endothelial cells. We also demonstrated that 
this increased nuclear localization was associated with a 
decrease in expression of IκBα. This overall activation 
of NFκB was associated with an increase in endothelial 
cell expression of the pro-inflammatory NFκB 
transcripts TNF-α, IL-6 and MCP-1, but not RAGE or 
cyclooxygenase. These results were the first to 
demonstrate that healthy human aging is associated with 
NFκB activation and selective upregulation of 
inflammatory proteins in the vascular endothelium. The 
expression of these cytokines in vascular endothelial 
cells was not related to plasma concentrations of TNF-
α, IL-6 or CRP. This indicates that among individuals, 
circulating levels of these proteins cannot be used to 
assess the inflammatory state of the vasculature per se. 
We postulate that the development of this pro-
inflammatory state in the vascular endothelium with 
healthy aging may play an important role in the 
increased susceptibility of older adults to atherosclerosis 
and other CVD [9]. 
 
Although these findings established that vascular 
inflammation developed with aging in healthy adults, 
our results did not provide evidence that this 
inflammatory state was contributing to vascular 
endothelial dysfunction in older adults.  We also had no 
insight into the mechanisms that might link 
inflammation to impaired endothelial function. One 
possibility was that NFκB activation increased 
oxidative stress, which, in turn, caused vascular 
endothelial dysfunction with aging.  Initial evidence for 
a role of NFκB signaling in age-associated vascular 
oxidative stress was provided by Donato et al. [6]. In 
that study, we found that total NFκB expression was 
positively related to nitrotyrosine, a marker of cellular 
oxidative stress, in vascular endothelial cells obtained 
from groups of young and older healthy adults.  
 
Recently, Pierce et al. [7] provided direct evidence that 
NFκB activation contributes to arterial endothelial 
dysfunction with aging. In a group of middle-aged and 
older obese adults, inhibition of endothelial cell NFκB 
nuclear translocation was achieved by four days of high 
dose treatment with the non-acetylated salicylate 
compound, salsalate, which suppresses NFκB signaling 
through inhibition of the NFκB activator, IκK.  
Salsalate improved endothelial dependent dilation in 
these older obese adults by 74% to values similar to 
young healthy adults.  Interestingly, acute intravenous 
infusion of the potent antioxidant, vitamin C, improved 
endothelial dependent dilation during placebo but did 
not augment dilation further it during the Salsalate 
condition. Salsalate also reduced nitrotyrosine and 
NADPH oxidase expression in vascular endothelial 
cells obtained from the subjects. Taken together, these 
findings provide experimental support for the idea that 
NFκB-dependent vascular inflammation tonically 
impairs vascular endothelial function with aging in 
humans by stimulating oxidative stress. 
 
In summary, NFκB is a key regulator of inflammation 
and oxidative stress. As a result of its unique ability to 
respond to both redox and inflammatory signaling in a 
cell, NFκB provides an effective “transducer” for feed 
forward activation of these processes. Recent findings 
from our laboratory provide evidence for an important 
role in NFκB in mediating vascular endothelial 
dysfunction in humans by stimulating inflammation and 
oxidative stress (Figure 1). Our results provide an 
experimental basis for future basic and clinical research 
studies focusing on the contribution of NFκB signaling 
to vascular aging. Basic research questions include the 
need for a greater understanding of the nuclear 
regulation of NFκB promoter binding and gene 
transcription in aging arteries. Among the key questions 
in this area are the mechanisms by which increases in 
NFκB nuclear translocation in vascular endothelial cells 
of older adults could lead to selective activation of 
genes involved in inflammation and oxidative stress. 
The roles of histone modification, DNA methylation, 
and transcription factor acetylation in such specific 
regulation of gene expression are worthy of attention. In 
cell culture, these processes modify NFκB promoter 
binding, but it is unknown how these mechanisms affect 
the vascular endothelium with aging. Clinical research 
directions could include determining if IκK inhibitors, 
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to reduce tissue specific oxidative stress and 
inflammation with aging and other age-related disease 
states. Inhibiting NFκB signaling might limit the 
vicious cycles of inflammation and oxidative stress, in 
part by interrupting synergistic crosstalk between these 
two processes.  Thus, modulation of NFκB may be 
viewed as a potential therapeutic target in the 
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